Movement Alert｜Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies

Market Focus

Jul 03

On July 3, Sino Biopharmaceutical rose 4.76% in regular trading, trading at HK$4.79/share, with turnover of HK$92.32 million.

On the news front, the National Healthcare Security Administration recently published the list of drugs that passed the preliminary formal review for the basic medical insurance catalog and commercial insurance innovative drug catalog adjustment. The review results showed increased application volume, significantly improved pass rate, and a predominance of new drugs among applications. Combined with the first-ever introduction of a pre-application mechanism, the outcome fully demonstrates the catalog adjustment's continued tilt toward innovative drugs. CITIC Construction Investment issued a research note expressing optimism on relevant innovative drug companies' medical insurance access and commercial insurance incremental opportunities.

Additionally, the broader pharmaceuticals sector showed strength, with CSPC Pharma up 4.11%, Hansoh Pharma up 4.02%, Hengrui Pharma up 1.35%, Luye Pharma up 5.38%, and Haixi Pharma up 10.79%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1163992621"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163992621\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163992621?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163992621","market":"us","top_or_hot":-1,"title":"Movement Alert｜Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies","media":"Market Focus","content":"<p><p>On July 3, Sino Biopharmaceutical rose 4.76% in regular trading, trading at HK$4.79/share, with turnover of HK$92.32 million.</p><p>On the news front, the National Healthcare Security Administration recently published the list of drugs that passed the preliminary formal review for the basic medical insurance catalog and commercial insurance innovative drug catalog adjustment. The review results showed increased application volume, significantly improved pass rate, and a predominance of new drugs among applications. Combined with the first-ever introduction of a pre-application mechanism, the outcome fully demonstrates the catalog adjustment's continued tilt toward innovative drugs. CITIC Construction Investment issued a research note expressing optimism on relevant innovative drug companies' medical insurance access and commercial insurance incremental opportunities.</p><p>Additionally, the broader pharmaceuticals sector showed strength, with CSPC Pharma up 4.11%, Hansoh Pharma up 4.02%, Hengrui Pharma up 1.35%, Luye Pharma up 5.38%, and Haixi Pharma up 10.79%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-03 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 3, Sino Biopharmaceutical rose 4.76% in regular trading, trading at HK$4.79/share, with turnover of HK$92.32 million.</p><p>On the news front, the National Healthcare Security Administration recently published the list of drugs that passed the preliminary formal review for the basic medical insurance catalog and commercial insurance innovative drug catalog adjustment. The review results showed increased application volume, significantly improved pass rate, and a predominance of new drugs among applications. Combined with the first-ever introduction of a pre-application mechanism, the outcome fully demonstrates the catalog adjustment's continued tilt toward innovative drugs. CITIC Construction Investment issued a research note expressing optimism on relevant innovative drug companies' medical insurance access and commercial insurance incremental opportunities.</p><p>Additionally, the broader pharmaceuticals sector showed strength, with CSPC Pharma up 4.11%, Hansoh Pharma up 4.02%, Hengrui Pharma up 1.35%, Luye Pharma up 5.38%, and Haixi Pharma up 10.79%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1163992621","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163992621","pubTimestamp":1783042846,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 3, Sino Biopharmaceutical rose 4.76% in regular trading, trading at HK$4.79/share, with turnover of HK$92.32 million.On the news front, the National Healthcare Security Administration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"动感快讯|中国生物制药常规交易涨4.76%国家医保目录调整利好创新药企业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"On July 3, Sino Biopharmaceutical rose 4.76% in regular trading, trading at HK$4.79/share, with turnover of HK$92.32 million.On the news front, the National Healthcare Security Administration recently published the list of drugs that passed the preliminary formal review for the basic medical insurance catalog and commercial insurance innovative drug catalog adjustment. The review results showed increased application volume, significantly improved pass rate, and a predominance of new drugs among applications. Combined with the first-ever introduction of a pre-application mechanism, the outcome fully demonstrates the catalog adjustment's continued tilt toward innovative drugs. CITIC Construction Investment issued a research note expressing optimism on relevant innovative drug companies' medical insurance access and commercial insurance incremental opportunities.Additionally, the broader pharmaceuticals sector showed strength, with CSPC Pharma up 4.11%, Hansoh Pharma up 4.02%, Hengrui Pharma up 1.35%, Luye Pharma up 5.38%, and Haixi Pharma up 10.79%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}